{
  "actions": [
    {
      "acted_at": "1992-10-05", 
      "committee": "House Committee on Energy and Commerce", 
      "references": [], 
      "status": "REFERRED", 
      "text": "Referred to the House Committee on Energy and Commerce.", 
      "type": "referral"
    }, 
    {
      "acted_at": "1992-11-20", 
      "in_committee": "House Committee on Energy and Commerce", 
      "references": [], 
      "subcommittee": "Health and the Environment", 
      "text": "Referred to the Subcommittee on Health and the Environment.", 
      "type": "referral"
    }
  ], 
  "amendments": [], 
  "bill_id": "hr6178-102", 
  "bill_type": "hr", 
  "committees": [
    {
      "activity": [
        "referral", 
        "in committee"
      ], 
      "committee": "House Energy and Commerce", 
      "committee_id": "HSIF"
    }, 
    {
      "activity": [
        "referral"
      ], 
      "committee": "House Energy and Commerce", 
      "committee_id": "HSIF", 
      "subcommittee": "Subcommittee on Health and Environment", 
      "subcommittee_id": "04"
    }
  ], 
  "congress": "102", 
  "cosponsors": [
    {
      "district": "4", 
      "name": "DeFazio, Peter A.", 
      "sponsored_at": "1992-10-05", 
      "state": "OR", 
      "thomas_id": "00279", 
      "title": "Rep", 
      "withdrawn_at": null
    }, 
    {
      "district": "1", 
      "name": "Schroeder, Patricia", 
      "sponsored_at": "1992-10-05", 
      "state": "CO", 
      "thomas_id": "01033", 
      "title": "Rep", 
      "withdrawn_at": null
    }
  ], 
  "enacted_as": null, 
  "history": {
    "awaiting_signature": false, 
    "enacted": false, 
    "vetoed": false
  }, 
  "introduced_at": "1992-10-05", 
  "number": "6178", 
  "official_title": "To provide for research on antiprogestin drugs through the National Institutes of Health.", 
  "popular_title": null, 
  "related_bills": [], 
  "short_title": "Antiprogestin Testing Act of 1992", 
  "sponsor": {
    "district": "3", 
    "name": "Wyden, Ron", 
    "state": "OR", 
    "thomas_id": "01247", 
    "title": "Rep", 
    "type": "person"
  }, 
  "status": "REFERRED", 
  "status_at": "1992-10-05", 
  "subjects": [
    "Abortion", 
    "Cancer", 
    "Cancer research", 
    "Contraceptives", 
    "Drugs", 
    "Health", 
    "Peer review organizations (Medicine)", 
    "Pharmaceutical research"
  ], 
  "subjects_top_term": "Drugs", 
  "summary": {
    "as": "Introduced", 
    "date": "1992-10-05", 
    "text": "Antiprogestin Testing Act of 1992 - Directs the Secretary of Health and Human Services to conduct and support research, including clinical trials, on antiprogestin drug safety and efficacy for any potential use, including termination of pregnancy, contraception, and therapeutic use for cancer, endocrine disorders, and endometriosis. Makes the research subject to provisions relating to institutional review boards and peer review."
  }, 
  "titles": [
    {
      "as": "introduced", 
      "title": "Antiprogestin Testing Act of 1992", 
      "type": "short"
    }, 
    {
      "as": "introduced", 
      "title": "To provide for research on antiprogestin drugs through the National Institutes of Health.", 
      "type": "official"
    }
  ], 
  "updated_at": "2013-02-02T20:15:03-05:00"
}